Nargess Arandi
8PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Aug 11, 2025
High donor regulatory B cells (Bregs) and their rapid recovery are associated with protection from the development of acute graft-versus-host disease (aGVHD) following allogeneic hematopoietic stem cell transplantation.Mani Ramzi, Maryam Hesamadini, Mohammadnabi Sanaei
|Apr 16, 2024
Abnormal frequency of the memory B cell subsets and plasmablasts in patients with congenital severe hemophilia A: correlation with "Inhibitor" formation.Omid Reza Zekavat, Yasaman Movahednezhad, Amin Shahsavani
|Jul 25, 2023
Altered frequency of FOXP3+ regulatory T cells is associated with development of inhibitors in patients with severe hemophilia A.Nargess Arandi, Omid Reza Zekavat, Negin Shokrgozar
|Jan 31, 2022
The prognostic significance of immune checkpoint receptor expression in patients with lymphoma: Association with disease status and clinical outcomes.Negin Shokrgozar, Mehdi Dehghani, Hossein Golmoghaddam
|Jul 29, 2021
Expression of the immune checkpoint receptors CTLA-4, LAG-3, and TIM-3 in β-thalassemia major patients: correlation with alloantibody production and regulatory T cells (Tregs) phenotype.Negin Shokrgozar, Mehran Karimi, Hossein Golmoghaddam
|Mar 15, 2021
The impact of selenium on regulatory T cell frequency and immune checkpoint receptor expression in patients with diffuse large B cell lymphoma (DLBCL).Mehdi Dehghani, Negin Shokrgozar, Mani Ramzi
Pageof 2
